| Literature DB >> 30482546 |
Jilmar A Murillo1, Juan F Gil1, Yulieth A Upegui2, Adriana M Restrepo2, Sara M Robledo2, Winston Quiñones1, Fernando Echeverri1, Aurelio San Martin3, Horacio F Olivo4, Gustavo Escobar5.
Abstract
We describe the in vitro activity of two natural isomeric ent-beyerene diterpenes, several derivatives and synthetic intermediates. Beyerenols 1 and 2 showed EC50 of 4.6 ± 9.4 and 5.3 ± 9.4 μg/mL against amastigotes of L. (V) brazilensis, with SI of 5.1 and 7.7, respectively. Beyerenol 1 was synthesized from stevioside. In vivo experiments with bereyenols showed cure in 50% of hamsters infected with L. (V) brazilensis topically applied as Cream I (beyerenol 1, 0.81%, w/w) and Cream III (beyerenol 2, 1.96%, w/w). These results suggest that beyerenols are potential candidates for cutaneous leishmaniasis chemotherapy by topical application. In vitro assays of amastigotes of L. (V) brazilensis showed EC50 of 1.1 ± 0.1 and 1.3 ± 0.04 μg/mL, with SI of 3.1 and 3.5 for hydrazone intermediates 10 and 11, respectively.Entities:
Keywords: Antileishmanial; Leishmania brazilensis; Semisynthesis; Steviol; ent-Beyerene diterpenoids
Mesh:
Substances:
Year: 2018 PMID: 30482546 DOI: 10.1016/j.bmc.2018.11.030
Source DB: PubMed Journal: Bioorg Med Chem ISSN: 0968-0896 Impact factor: 3.641